Clinical Trial: Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942728) titled 'Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment' on March 24.

Brief Summary: Globally, approximately 55 million people suffer from dementia, and 60-70% of cases are due to Alzheimer's disease (AD). Increasing scientific evidence highlights that the pathological changes underlying AD and other forms of dementia begin long before the onset of symptoms. Mild cognitive impairment (MCI) is a clinical condition that in people over 65 shows a prevalence ranging from 3% to 22%. The characteristics of MCI are the presence of a subjective memory disorder and a reduced ability to learn new information...